Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Overactive Bladder
- Sponsor
- Unity Health Toronto
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Recall
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Background: Overactive bladder (OAB) is a common condition among postmenopausal women, requiring a multifaceted treatment approach that requires patient retention of information given to them in clinic. Recall of recommendations is a key component of compliance. Supplemental educational tools such as handouts and audiovisual information have been investigated for their ability to improve patients' recall of information and increase satisfaction with the clinical encounter.
Objective: To determine if a written list of seven management strategies for overactive bladder leads to improved immediate and delayed recall of these recommendations in postmenopausal women presenting with OAB compared to a traditional verbal discussion.
Methods: In this single-blind, randomized controlled trial, patients' immediate and delayed (2-week) recall of seven OAB management strategies will be compared between two groups. The intervention group will receive a handwritten list during their verbal discussion of OAB treatment while the control group will receive standard care (verbal discussion only). Immediate and delayed recall will be assessed by a member of the study team who has been blinded to participants' group assignments.
Results: The results of this study may guide clinicians in the most effective mode of providing treatment recommendations to post-menopausal patients with OAB.
Investigators
Eligibility Criteria
Inclusion Criteria
- •New diagnosis of overactive bladder
- •post-menopausal
Exclusion Criteria
- •Pre-existing diagnosis of dementia or other cognitive disorders
- •Patients with mixed incontinence
- •Non-English speaking
- •Patients with contraindications to taking vaginal estrogen or anticholinergic medications
Outcomes
Primary Outcomes
Recall
Time Frame: 0 and 2 weeks
Mean number of treatment strategies recalled (scored out of seven) immediately and two weeks after the clinic appointment.